MASS News and Press, 908 Devices Inc.

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately. Ms....

Updated technology enables first responders to identify and quantify approximately 5,000 substances in mere seconds for a swift and definitive response 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced an ...

2024-06-01 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-23 09:17:40 ET Summary Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opport...

2024-05-02 18:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-30 07:56:00 ET More on 908 Devices 908 Devices: Rare Early-Stage Bioprocess Investment Opportunity 908 Devices beats top-line and bottom-line estimates; updates FY24 outlook Read the full article on Seeking Alpha For further details see: 908 Devic...

2024-04-30 07:49:58 ET More on 908 Devices 908 Devices: Rare Early-Stage Bioprocess Investment Opportunity 908 Devices GAAP EPS of -$0.23 beats by $0.03, revenue of $14.35M beats by $0.19M Read the full article on Seeking Alpha For further details see: 90...

2024-04-30 07:48:36 ET More on 908 Devices 908 Devices: Rare Early-Stage Bioprocess Investment Opportunity 908 Devices Inc. (MASS) Q4 2023 Earnings Call Transcript 908 Devices Inc. 2023 Q4 - Results - Earnings Call Presentation 908 Devices Q1 2024 Earnings Pr...

First quarter 2024 product and service revenue increased 8% compared to prior year, driven by a 20% increase in handheld revenue Acquired RedWave Technology, expanding forensics product portfolio for point-of-need applications 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpos...

Adds optical spectroscopy to the company’s technology platform for point-of-need applications 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biochemical analysis, announces that it has completed the acquisit...